V1 sact_regimen
730,471 rows · 12 columns
| MERGED_REGIMEN_ID | MERGED_TUMOUR_ID | HEIGHT_AT_START_OF_REGIMEN | WEIGHT_AT_START_OF_REGIMEN | INTENT_OF_TREATMENT | DATE_DECISION_TO_TREAT | START_DATE_OF_REGIMEN | MAPPED_REGIMEN | CLINICAL_TRIAL | CHEMO_RADIATION | MERGED_PATIENT_ID | BENCHMARK_GROUP |
|---|---|---|---|---|---|---|---|---|---|---|---|
| 300003792 | 300002656 | 1.65 | 59.6 | Curative (C) | 2014-04-02 | 2014-04-09 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 300016860 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003793 | 300006001 | null | null | null | 2012-10-30 | 2013-10-28 | CARBOPLATIN + PACLITAXEL | 02 | N | 300016865 | CARBOPLATIN + PACLITAXEL |
| 300003794 | 300002657 | 1.59 | 81.5 | Neo-adjuvant (N) | 2017-09-15 | 2017-10-06 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 300016876 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003795 | 300002657 | 1.78 | 136 | Neo-adjuvant (N) | 2017-03-30 | 2017-04-06 | Cisplatin +Fluorouracil (3 wk) | N | N | 300016876 | CISPLATIN + FLUOROURACIL |
| 300003796 | 300002657 | 1.8 | null | Adjuvant (A) | 2018-03-30 | 2018-03-31 | Carboplatin + Paclitaxel (3 weekly) | N | N | 300016876 | CARBOPLATIN + PACLITAXEL |
| 300003797 | 300002657 | 1.63 | 74 | Curative (C) | 2014-01-11 | 2014-01-29 | Cetuximab 7 day (>Cycle 2) | N | Y | 300016876 | CETUXIMAB |
| 300003798 | 300002658 | 1.75 | 99.05 | Curative (C) | 2015-09-04 | 2015-11-07 | Cisplatin + Docetaxel +Fluorouracil | 2 | N | 300016886 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003799 | 300002659 | 1.64 | 90.8 | Curative (C) | 2017-11-09 | 2017-11-25 | Cetuximab 7 day (Cycle 1) | N | Y | 300016890 | CETUXIMAB |
| 300003800 | 300002660 | 1.69 | 90 | Palliative (P) | 2013-04-08 | 2013-04-08 | SIEGE TRIAL | N | N | 300016892 | TRIAL |
| 300003801 | 300002661 | 1.6 | 88 | Curative (C) | 2013-02-18 | 2013-03-12 | Cetuximab + Radiotherapy Maint | N | Y | 300016893 | CETUXIMAB + RT |
| 300003802 | 300002662 | 1.57 | 87 | Neo-adjuvant (N) | 2013-03-13 | 2013-03-26 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 300016895 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003803 | 300002663 | null | 88.1 | Neo-adjuvant (N) | null | 2013-06-19 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300016896 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003804 | 300002664 | 1.7 | 60.2 | Curative (C) | 2017-06-06 | 2017-07-05 | CETUXIMAB + RT | N | Y | 300016908 | CETUXIMAB + RT |
| 300003805 | 300002665 | 1.51 | 74.5 | Adjuvant (A) | 2016-11-29 | 2016-12-18 | Capecitabine | N | N | 300016914 | CAPECITABINE |
| 300003806 | 300002665 | 1.6 | 95 | Disease modification (D) | 2017-06-08 | 2017-06-19 | Capecitabine | 02 | N | 300016914 | CAPECITABINE |
| 300003807 | 300002666 | 1.54 | null | Palliative (P) | 2017-10-10 | 2018-01-15 | CISPLATIN + FLUOROURACIL | N | N | 300016929 | CISPLATIN + FLUOROURACIL |
| 300003808 | 300002667 | 1.73 | 88.5 | Adjuvant (A) | 2015-05-04 | 2015-05-04 | Capecitabine | 02 | N | 300016931 | CAPECITABINE |
| 300003809 | 300002667 | 1.54 | 81 | Curative (C) | 2015-04-25 | 2015-05-28 | BILCAP TRIAL | 02 | N | 300016931 | TRIAL |
| 300003810 | 300002667 | 1.75 | 90 | Curative (C) | 2015-07-18 | 2015-08-13 | CETUXIMAB + RT | N | Y | 300016931 | CETUXIMAB + RT |
| 300003811 | 300002668 | 1.56 | 60.6 | Adjuvant (A) | 2016-02-23 | 2016-02-27 | Capecitabine | N | N | 300016947 | CAPECITABINE |
| 300003812 | 300002669 | 1.74 | 80.55 | Neo-adjuvant (N) | 2014-11-01 | 2014-11-07 | CISPLATIN + DOCETAXEL + FLUOROURACIL | 02 | N | 300016949 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003813 | 300002669 | 1.56 | 108 | Palliative (P) | 2016-11-06 | 2016-11-13 | Capecitabine | N | N | 300016949 | CAPECITABINE |
| 300003814 | 300002669 | 1.71 | 95.9 | Palliative (P) | 2015-06-30 | 2015-06-30 | CARBOPLATIN + PACLITAXEL | 2 | N | 300016949 | CARBOPLATIN + PACLITAXEL |
| 300003815 | 300002670 | null | null | Curative (C) | 2015-07-30 | 2015-07-30 | Trial Unspecified | N | N | 300016967 | TRIAL |
| 300003816 | 300002671 | 1.65 | 65 | Adjuvant (A) | 2017-10-16 | 2017-10-24 | Capecitabine | N | N | 300016970 | CAPECITABINE |
| 300003817 | 300006006 | 1.77 | 82 | Palliative (P) | 2017-06-09 | 2017-06-28 | Trial Unspecified | N | N | 300016973 | TRIAL |
| 300003818 | 300002672 | null | 70.15 | Curative (C) | 2011-08-15 | 2013-07-09 | Cetuximab + Radiotherapy Load | N | N | 300016974 | CETUXIMAB + RT |
| 300003819 | 300002673 | 1.75 | 73 | Curative (C) | 2015-05-24 | 2015-06-08 | Cetuximab + Radiotherapy Load | N | Y | 300016978 | CETUXIMAB + RT |
| 300003820 | 300002673 | 1.62 | 66 | null | 2014-06-21 | 2014-06-26 | Cisplatin +Fluorouracil (3 wk) | null | N | 300016978 | CISPLATIN + FLUOROURACIL |
| 300003821 | 300002673 | 1.84 | 72.8 | Neo-adjuvant (N) | 2014-08-25 | 2015-04-15 | Cisplatin +Fluorouracil (2 wk) | 02 | N | 300016978 | CISPLATIN + FLUOROURACIL |
| 300003822 | 300002673 | 1.67 | 72.2 | Curative (C) | 2014-04-21 | 2014-04-27 | Trial Unspecified | null | null | 300016978 | TRIAL |
| 300003823 | 300002674 | null | 118.2 | Neo-adjuvant (N) | 2016-03-14 | 2016-03-27 | CISPLATIN + FLUOROURACIL | N | N | 300017004 | CISPLATIN + FLUOROURACIL |
| 300003824 | 300002675 | 1.52 | 48 | Curative (C) | 2016-06-21 | 2016-07-07 | CETUXIMAB | N | Y | 300017005 | CETUXIMAB |
| 300003825 | 300002676 | 1.65 | 59.6 | Curative (C) | 2015-10-29 | 2015-11-06 | CETUXIMAB | 02 | Y | 300017007 | CETUXIMAB |
| 300003826 | 300006008 | null | 65.4 | Curative (C) | 2016-09-01 | 2016-09-01 | CISPLATIN + FLUOROURACIL | N | N | 300017009 | CISPLATIN + FLUOROURACIL |
| 300003827 | 300002677 | 1.5 | 90.9 | Adjuvant (A) | 2016-04-27 | 2016-04-29 | Capecitabine | N | N | 300017012 | CAPECITABINE |
| 300003828 | 300002678 | 1.5 | null | Curative (C) | 2015-07-23 | 2015-07-29 | CISPLATIN + DOCETAXEL + FLUOROURACIL | N | N | 300017014 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003829 | 300002679 | 1.65 | 74.7 | Disease modification (D) | 2016-08-26 | 2016-09-12 | Cisplatin + Docetaxel +Fluorouracil | N | N | 300017018 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003830 | 300002680 | 1.83 | 71 | Neo-adjuvant (N) | 2013-05-02 | 2013-05-08 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 300017019 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003831 | 300002681 | 1.7 | 55.5 | Curative (C) | 2016-07-23 | 2016-08-15 | Trial Unspecified | N | N | 300017026 | TRIAL |
| 300003832 | 300002681 | 1.73 | 42.6 | Neo-adjuvant (N) | 2015-02-11 | 2015-02-27 | Cisplatin + Docetaxel +Fluorouracil | 02 | N | 300017026 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003833 | 300002681 | 1.85 | 44 | Curative (C) | 2016-01-17 | 2016-02-18 | CETUXIMAB + RT | 02 | Y | 300017026 | CETUXIMAB + RT |
| 300003834 | 300007964 | 1.68 | 108.5 | Neo-adjuvant (N) | 2014-08-04 | 2014-08-04 | Cisplatin +Fluorouracil (2 wk) | 02 | N | 300017043 | CISPLATIN + FLUOROURACIL |
| 300003835 | 300007964 | 1.62 | null | Curative (C) | 2016-04-28 | 2016-04-29 | Cisplatin + Docetaxel +Fluorouracil | N | null | 300017043 | CISPLATIN + DOCETAXEL + FLUOROURACIL |
| 300003836 | 300002682 | 1.63 | 64.9 | Disease modification (D) | 2017-11-01 | 2018-02-13 | CARBOPLATIN + PACLITAXEL | N | N | 300017051 | CARBOPLATIN + PACLITAXEL |
| 300003837 | 300002683 | 1.59 | 74 | Curative (C) | null | 2013-08-23 | CETUXIMAB | Y | null | 300017054 | CETUXIMAB |
| 300003838 | 300002684 | 1.7 | 78.1 | Curative (C) | 2016-11-01 | 2016-12-11 | CETUXIMAB + RT | 02 | Y | 300017059 | CETUXIMAB + RT |
| 300003839 | 300002685 | 1.67 | 54.6 | Adjuvant (A) | 2015-01-12 | 2015-01-22 | Capecitabine | 02 | N | 300017066 | CAPECITABINE |
| 300003840 | 300002685 | null | null | Palliative (P) | null | 2017-08-24 | CISPLATIN + FLUOROURACIL | N | N | 300017066 | CISPLATIN + FLUOROURACIL |
| 300003841 | 300002686 | 1.45 | 72 | Neo-adjuvant (N) | 2017-09-27 | 2017-09-27 | Cisplatin +Fluorouracil (3 wk) | Y | N | 300017071 | CISPLATIN + FLUOROURACIL |